Robert Langer wins BBVA Foundation Frontiers of Knowledge Award
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
The five-year collaboration aims to accelerate the translation of breakthrough engineering and biology for human health.
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma.
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Faculty members Angela Belcher, Pablo Jarillo-Herrero, and Ronitt Rubinfeld elected by peers for outstanding contributions to research.
The 2nd Annual Research Slam featured three-minute talks on cutting-edge research from across MIT in an engaging public showcase and competition.
MIT biological engineers have developed a simple way to identify B or T cells that interact with viral or bacterial proteins.
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies.
MIT senior Daniel Zhang aims to provide hope for young patients and support to young students.
A new analysis offers guidance on the size of nanoparticles that could be most effective at stopping internal bleeding.
Departments of Biology and Brain and Cognitive Sciences welcome new professors.
The technique can help predict a cell’s path over time, such as what type of cell it will become.
A computational study shows that dozens of mutations help the virus’ spike protein evade antibodies that target SARS-CoV-2.